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Taudien et al. (2016-in this issue) present their results from a study
using a promising alternative taking advantage of high-throughput DNA
sequencing. The authors selected 59 patients from a roughly 4000 patient
cohort, and classiﬁed them based on two extreme phenotypes: group A
(n=32) comprised themost favorable cases, including patientswho sur-
vived sepsis despite the administration of inappropriate antibiotic thera-Sepsis results froma systemic inﬂammatory response to bacterial in-
fections, which is characterized by a high production of immune re-
sponse mediators that can result in a multiple organ failure and worse
outcomes (Cohen, 2002). The incidence of sepsis is increasing and varies
between countries from 9% to 37% of patients admitted to the intensive
care units (ICU). Furthermore, it continues to be a common cause of
death in adult ICU, causing an overall mortality of 30% and rising to
50% when the most severe form of the syndrome is present (Martin et
al., 2003; Blanco et al., 2008).
It is well known that an early recognition of sepsis and an expedite
initiation of the appropriate treatment improves the chances of patient
survival. Despite theheterogeneity and complexity of this clinical entity,
genetics has been proposed as a potential tool to provide early patient
risk stratiﬁcation. In support of this possibility, animal models, family
aggregation studies and genetic analysis in humans provide a link be-
tween inherited factors and the response to infections and fatal out-
comes (Petersen et al., 2010; Mikacenic et al., 2013; Ferguson et al.,
2015). This has motivated the study of genetic factors as predictors of
risk and prognosis during sepsis. However, although many of these
studies have reported positive associations in candidate genes or partic-
ular polymorphisms, ﬁndings have often been inconsistent (Clark and
Baudouin, 2006). In this sense, genome-wide association studies
(GWAS) constitute a strong methodological advance on a genomic
scale, as they have allowed identifying well-founded genetic risks that
are common in the population. Only a few GWAS related with sepsis
have been published to date (Man et al., 2013; Rautanen et al., 2015;
Scherag et al., 2016-in this issue), all of which identiﬁed common genet-
ic variants associated with 28-day mortality.
Although more GWAS on sepsis traits will be accomplished in the
coming years, it is worth noting that these studies allow analyzing a/j.ebiom.2016.08.043, http://
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py, whereas group B (n= 27) was composed of patients with the worst
disease course despite being younger, received the appropriate treatment,
and had no comorbidities. Those patients were sequenced for their
exome, which roughly corresponds to the portion of DNA that codes for
functional genes, in order to assess the role of rare single nucleotide var-
iants (SNVs) in sepsis course. Based on advanced semantic classiﬁcation
algorithms and on themost likely damaging rare SNVs, the authors devel-
oped amodel predictingdisease course involving cell signaling and innate
immunity genes. Themodel attained N75% accuracy, sensitivity and spec-
iﬁcity, and was validated in an independent but smaller (n=15) cohort.
Strikingly, damaging rare SNVs conferred a protective effect to the disease
course after sepsis. Extensive sequencing of further patients will be need-
ed to independently validate and reﬁne thisﬁnding, andwill probably un-
ravel novel genes with potential implications in sepsis prognosis. In
addition, based on the reported ethnic disparities in sepsis incidence
and mortality (Martin et al., 2003), those studies should include samples
of diverse ethnicity to verify the robustness of classiﬁcation.
Personalized information, including that provided by our genetic
makeup, is profoundly changing themedical practice. For this to happen
in the ICUs, many more genes of interest for sepsis risk and prognosis
need to be discovered. Focusing on particular patient populations
should provide optimal approaches. In addition, the application of
multi-level clinical and genetic data analysis, as exempliﬁed by
Taudien et al. (2016-in this issue) and the accompanying study in
EBioMedicine (Scherag et al., 2016-in this issue), illustrate a way to
offer joint support to determine genes of interest for developing person-
alized interventions in sepsis.
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